Fisher & Paykel Healthcare's share price fell sharply after the respiratory products maker said it expects its operating revenue to be between $1.675 billion and $1.70b in the current financial year to March 31.
The previous year's revenue for New Zealand's biggest company by market cap came to $1.97b.
The latest revenue forecast is slightly short of a Bloomberg consensus of market expectations of $1.76b.
The company's shares last traded at $25.69, down $2.21 or 7.9 per cent from Monday's closing level. The stock has dropped by more than 10 per cent over the last 12 months.
The 2021 year was a big one for F&P Healthcare, with earnings arising from the Covid-19 pandemic helping to drive an 82 per cent lift in net profit to a record $524m.